This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A First Look at Efruxifermin as a therapy for nonalcoholic steatohepatitis

Ticker(s): AKRO

Who's the expert?

Institution: NYU Langone Great Neck Medical

  • Gastroenterologist who treats 750 patients with NASH.
  • Assistant Professor of  gastroenterology and hepatology at NYU Langone Health Tisch Hospital
  • Comfortable discussing efruxifermin and its HARMONY Phase IIb trial

Interview Goal
Discussing the potential of efruxifermin and its HARMONY Phase IIb trial

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.